Given the impact of the illegal medicines trade on public health in Latin America, on confidence in the health system and on ...
US biopharma company Mineralys Therapeutics today announced the presentation of a new analysis from its pivotal Phase III ...
Leading Swiss contract development and manufacturing organization (CDMO) Lonza and Onava, a US biotech building an AI-native ...
Data presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 showed that Eli Lilly’s ...
Israel-based Teva Pharmaceutical Industries US subsidiary today revealed that the US Food and Drug Administration (FDA) has ...
Privately-held Endeavor BioMedicines said its Phase IIb WHISTLE-PF trial of taladegib (ENV-101) met its primary endpoint in ...
Iambic Therapeutics, the San Diego-based AI drug discovery company, has set terms for a Nasdaq initial public offering of 9,375,000 shares priced at $15 to $17 each, under the proposed ticker IAM, ...
Belgo-Dutch immunology specialist argenx announced that it will discontinue the Phase III UNITY study of efgartigimod ...
US biotech Outlook Therapeutics, which is specializing in the development and commercialization of Lytenava (bevacizumab-vikg ...
India's pharmaceutical manufacturing industry is entering a delicate phase in its development. As uncertainty grows over its ...
When the World Health Organization (WHO) updates its Model List of Essential Medicines (EML), it gives governments a ...
Belgian life sciences company SpectaCell has launched with 6 million euros ($6.7 million) in seed financing to develop a cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results